News
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
Kicking off this week in Chicago, this year’s American Association for Cancer Research conference will feature presentations ...
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
The U.S. has detected the NB.1.8.1 COVID-19 variant, dominant in China, through airport screenings and health departments ...
A new COVID-19 variant, NB.1.8.1, linked to a surge in cases across China and parts of Asia, has now been detected in the ...
4h
Zacks Investment Research on MSNPharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & MoreNovo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...
5h
Daily Express US on MSNNew Covid variant lands in US after ripping through countries, killing some in TaiwanThe travelers with cases linked to the NB.1.8.1 variant have been arriving at airports in California, Washington state, ...
The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to pause dosing in another study.
April China's Copper Concentrate Imports: Unexpected Yet Reasonable[SMM Analysis] [SMM Analysis:April China's Copper Concentrate Imports: Unexpected Yet Reasonable ] In April 2025, China's imports of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results